by Daniel ShvartsmanInvesting.com - Wednesday trading saw the market continue its recovery from the volatile start to the trading year, with the S&P 500 finishing up nearly 1%...
By Dhirendra TripathiInvesting.com – Biogen stock (NASDAQ:BIIB) slumped 9% in Wednesday’s premarket trading after a decision to restrict Medicare coverage of certain alzheimer’s...
By Farah Master HONG KONG (Reuters) - If investors in China's biotech industry needed one more sign that the sector is coming of age, then a major licensing deal RemeGen Co Ltd...
Despite Wall Street’s ongoing bearish sentiment, new exchange-traded funds (ETF) have continued to reach the market in impressive numbers in 2022. ETFs listed in the US...
Concerns over high inflation levels and the war in Ukraine have meant increased volatility for stocks on Wall Street and other exchanges around the world. For instance, the DAX...
A slew of macroeconomic difficulties washed over Wall Street in the first two months of 2022, leading to heightened market volatility. So, investors have been paying close...
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women’s health. In addition, the company supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. It has collaboration with Gilead Sciences, Inc. for COVID-19; and a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza. The company also has a collaboration with Bristol Myers Squibb to advance personalized healthcare through digital pathology solutions. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Neutral | Sell | Neutral |
| Technical Indicators | Strong Sell | Strong Sell | Buy | Strong Buy | Sell |
| Summary | Strong Sell | Strong Sell | Neutral | Neutral | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 3.89 | 4.45 | 3.78 | -0.460 | -10.57% | 894.80K | NASDAQ | |||
| 92.65 | 93.89 | 89.52 | +1.49 | +1.63% | 109.22M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 8.16 | 8.19 | 7.96 | -0.08 | -0.97% | 4.69M | NYSE | |||
| 0.1922 | 0.2025 | 0.1896 | -0.0158 | -7.60% | 1.43M | NYSE | |||
| 82.31 | 84.07 | 81.07 | -0.16 | -0.19% | 22.86M | NYSE | |||
| 39.40 | 39.60 | 38.84 | +0.64 | +1.65% | 5.85M | NYSE | |||
| 1.15 | 1.15 | 1.11 | +0.0200 | +1.77% | 4.63M | NYSE | |||
| 7.92 | 7.95 | 7.80 | -0.06 | -0.75% | 6.16M | NASDAQ | |||
| 51.16 | 51.62 | 50.34 | -0.35 | -0.68% | 6.79M | NYSE | |||
| 133.07 | 133.46 | 129.52 | +3.82 | +2.96% | 3.87M | NYSE | |||
| 1.43 | 1.52 | 1.20 | +0.090 | +6.72% | 29.99M | NASDAQ | |||
| 143.98 | 144.49 | 140.91 | +0.48 | +0.33% | 55.73K | NYSE | |||
| 13.52 | 13.54 | 12.94 | +0.51 | +3.92% | 387.60K | NASDAQ | |||
| 33.93 | 34.11 | 33.56 | +0.38 | +1.13% | 48.14K | NASDAQ |